Newsweek and Statista have shared their 2027 list of the world’s top 300 hospitals for cardiology. Nine of the top 20 are based in the United States.

Heart failure patients with a CardioMEMS implant can now monitor their own pulmonary artery pressure readings and receive clinician feedback through a smartphone app.

The Acticor Sky CRT-DX, which secured FDA approval in April, has officially made its debut in the United States.

"We really should have a system that is patient-centric, physician-led, and professionally managed, but in a cost-effective way," Rick Snyder, MD, said.

CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 

TAVR Assist+ was built to capture patient measurements and perform other straightforward tasks. This gives cardiologists more time to make critical treatment decisions.

Orforglipron was linked to consistent weight loss in addition to reductions in waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol and high-sensitivity C-reactive protein. In terms of safety, it was found to be noninferior to insulin glargine.

MRI scans have traditionally been used for extracellular volume assessments. That is starting to change, however, as cardiac CT moves beyond its typical focus on the coronary arteries.

Some parents may be unsure about giving their children these medications. However, it can be worth it to avoid a lifetime of high blood pressure and other potentially harmful health conditions.

A new STEMI medication from CeleCor Therapeutics is now one step closer to a potential FDA approval.

The overall mortality rate for U.S. patients with cardiovascular disease has improved significantly in recent years. At the same time, however, care gaps remain that must be addressed.